Julia B Kahn1, Russell G Port2, Stewart A Anderson2, Douglas A Coulter3. 1. Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania. 3. Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania. Electronic address: coulterd@email.chop.edu.
Abstract
BACKGROUND: 22q11.2 deletion syndrome (22qDS) manifests with myriad symptoms, including multiple neuropsychiatric disorders. Complications associated with the polygenic haploinsufficiency make 22qDS symptoms particularly difficult to manage with traditional therapeutic approaches. However, the varying mechanistic consequences often culminate to generate inappropriate regulation of neuronal circuit activity. We explored whether managing this aberrant activity in adults could be a therapeutically beneficial strategy. METHODS: To assess and dissect hippocampal circuit function, we performed functional imaging in acute slices and targeted eloquent circuits (specific subcircuits tied to specific behavioral tasks) to provide relevant behavioral outputs. For example, the ventral and dorsal CA1 regions critically support social and spatial discrimination, respectively. We focally introduced chemogenetic constructs in 34 control and 24 22qDS model mice via adeno-associated viral vectors, driven by excitatory neuron-specific promoter elements, to manipulate circuit recruitment in an on-demand fashion. RESULTS: 22qDS model mice exhibited CA1 excitatory ensemble hyperexcitability and concomitant behavioral deficits in both social and spatial memory. Remarkably, acute chemogenetic inhibition of pyramidal cells successfully corrected memory deficits and did so in a regionally specific manner: ventrally targeted constructs rescued only social behavior, while those expressed dorsally selectively affected spatial memory. Additionally, manipulating activity in control mice could recapitulate the memory deficits in a regionally specific manner. CONCLUSIONS: These data suggest that retuning activity dysregulation can rescue function in disease-altered circuits, even in the face of a polygenetic haploinsufficiency with a strong developmental component. Targeting circuit excitability in a focal, modular manner may prove to be an effective therapeutic for treatment-resistant symptoms of mental illness.
BACKGROUND: 22q11.2 deletion syndrome (22qDS) manifests with myriad symptoms, including multiple neuropsychiatric disorders. Complications associated with the polygenic haploinsufficiency make 22qDS symptoms particularly difficult to manage with traditional therapeutic approaches. However, the varying mechanistic consequences often culminate to generate inappropriate regulation of neuronal circuit activity. We explored whether managing this aberrant activity in adults could be a therapeutically beneficial strategy. METHODS: To assess and dissect hippocampal circuit function, we performed functional imaging in acute slices and targeted eloquent circuits (specific subcircuits tied to specific behavioral tasks) to provide relevant behavioral outputs. For example, the ventral and dorsal CA1 regions critically support social and spatial discrimination, respectively. We focally introduced chemogenetic constructs in 34 control and 24 22qDS model mice via adeno-associated viral vectors, driven by excitatory neuron-specific promoter elements, to manipulate circuit recruitment in an on-demand fashion. RESULTS: 22qDS model mice exhibited CA1 excitatory ensemble hyperexcitability and concomitant behavioral deficits in both social and spatial memory. Remarkably, acute chemogenetic inhibition of pyramidal cells successfully corrected memory deficits and did so in a regionally specific manner: ventrally targeted constructs rescued only social behavior, while those expressed dorsally selectively affected spatial memory. Additionally, manipulating activity in control mice could recapitulate the memory deficits in a regionally specific manner. CONCLUSIONS: These data suggest that retuning activity dysregulation can rescue function in disease-altered circuits, even in the face of a polygenetic haploinsufficiency with a strong developmental component. Targeting circuit excitability in a focal, modular manner may prove to be an effective therapeutic for treatment-resistant symptoms of mental illness.
Authors: R E Gur; J J Yi; D M McDonald-McGinn; S X Tang; M E Calkins; D Whinna; M C Souders; A Savitt; E H Zackai; P J Moberg; B S Emanuel; R C Gur Journal: Mol Psychiatry Date: 2014-01-21 Impact factor: 15.992
Authors: Maureen McHugo; Pratik Talati; Kristan Armstrong; Simon N Vandekar; Jennifer Urbano Blackford; Neil D Woodward; Stephan Heckers Journal: Am J Psychiatry Date: 2019-10-18 Impact factor: 18.112
Authors: Karen J Thompson; Elham Khajehali; Sophie J Bradley; Jovana S Navarrete; Xi Ping Huang; Samuel Slocum; Jian Jin; Jing Liu; Yan Xiong; Reid H J Olsen; Jeffrey F Diberto; Kristen M Boyt; Melanie M Pina; Dipanwita Pati; Colin Molloy; Christoffer Bundgaard; Patrick M Sexton; Thomas L Kash; Michael J Krashes; Arthur Christopoulos; Bryan L Roth; Andrew B Tobin Journal: ACS Pharmacol Transl Sci Date: 2018-07-27
Authors: Jordi Bonaventura; Mark A G Eldridge; Feng Hu; Juan L Gomez; Marta Sanchez-Soto; Ara M Abramyan; Sherry Lam; Matthew A Boehm; Christina Ruiz; Mitchell R Farrell; Andrea Moreno; Islam Mustafa Galal Faress; Niels Andersen; John Y Lin; Ruin Moaddel; Patrick J Morris; Lei Shi; David R Sibley; Stephen V Mahler; Sadegh Nabavi; Martin G Pomper; Antonello Bonci; Andrew G Horti; Barry J Richmond; Michael Michaelides Journal: Nat Commun Date: 2019-10-11 Impact factor: 14.919
Authors: Ralda Nehme; Olli Pietiläinen; Mykyta Artomov; Matthew Tegtmeyer; Vera Valakh; Leevi Lehtonen; Christina Bell; Tarjinder Singh; Aditi Trehan; John Sherwood; Danielle Manning; Emily Peirent; Rhea Malik; Ellen J Guss; Derek Hawes; Amanda Beccard; Anne M Bara; Dane Z Hazelbaker; Emanuela Zuccaro; Giulio Genovese; Alexander A Loboda; Anna Neumann; Christina Lilliehook; Outi Kuismin; Eija Hamalainen; Mitja Kurki; Christina M Hultman; Anna K Kähler; Joao A Paulo; Andrea Ganna; Jon Madison; Bruce Cohen; Donna McPhie; Rolf Adolfsson; Roy Perlis; Ricardo Dolmetsch; Samouil Farhi; Steven McCarroll; Steven Hyman; Ben Neale; Lindy E Barrett; Wade Harper; Aarno Palotie; Mark Daly; Kevin Eggan Journal: Nat Commun Date: 2022-06-27 Impact factor: 17.694
Authors: Tomas E Sachella; Marina R Ihidoype; Christophe D Proulx; Diego E Pafundo; Jorge H Medina; Pablo Mendez; Joaquin Piriz Journal: Neuropsychopharmacology Date: 2022-02-25 Impact factor: 8.294